MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 97 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $58,000 | -52.1% | 18,769 | -36.6% | 0.00% | – |
| Q4 2016 | $121,000 | -30.1% | 29,616 | +8.6% | 0.00% | – |
| Q3 2016 | $173,000 | +31.1% | 27,263 | +11.3% | 0.00% | – |
| Q2 2016 | $132,000 | -30.9% | 24,488 | +7.5% | 0.00% | – |
| Q1 2016 | $191,000 | +61.9% | 22,776 | +52.6% | 0.00% | – |
| Q4 2015 | $118,000 | -65.5% | 14,929 | -62.9% | 0.00% | -100.0% |
| Q3 2015 | $342,000 | -29.9% | 40,221 | +2.0% | 0.00% | 0.0% |
| Q2 2015 | $488,000 | +17.6% | 39,439 | +13.0% | 0.00% | 0.0% |
| Q1 2015 | $415,000 | -0.2% | 34,899 | -5.1% | 0.00% | 0.0% |
| Q4 2014 | $416,000 | +135.0% | 36,791 | +82.0% | 0.00% | – |
| Q3 2014 | $177,000 | +142.5% | 20,210 | +39.8% | 0.00% | – |
| Q1 2014 | $73,000 | -16.1% | 14,453 | -11.5% | 0.00% | – |
| Q4 2013 | $87,000 | +102.3% | 16,330 | +42.7% | 0.00% | – |
| Q3 2013 | $43,000 | – | 11,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,442,159 | $15,508,000 | 3.96% |
| Consonance Capital Management LP | 5,950,225 | $37,784,000 | 3.64% |
| Lagoda Investment Management, L.P. | 1,870,777 | $11,879,000 | 3.57% |
| ALTFEST L J & CO INC | 39,490 | $1,508,000 | 1.00% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $525,000 | 0.49% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 8,894,008 | $56,477,000 | 0.46% |
| Cannell & Co. | 1,611,678 | $10,234,000 | 0.37% |
| Portolan Capital Management | 412,189 | $2,617,000 | 0.36% |
| Virtus ETF Advisers LLC | 100,090 | $636,000 | 0.31% |
| INDUS CAPITAL PARTNERS, LLC | 500,000 | $3,175,000 | 0.30% |